BioCentury | Jun 24, 2020
Finance

AsclepiX aims for basket of retinal indications with $35M series A

...November 2019 that it had raised $5 million via a convertible note from Barer, Rapha, Salem Partners...
BioCentury | Mar 10, 2014
Financial News

ZS Pharma completes venture financing

...Management; Adage Capital Management; Sofinnova Ventures; Alta Partners; Devon Park Bioventures; 3x5 Special Opportunity Partners; Salem Partners...
BioCentury | Mar 6, 2014
Financial News

ZS Pharma raised $55 million in D round

...also participated, along with existing investors Alta Partners; Devon Park Bioventures; 3x5 Special Opportunity Fund; Salem Partners...
BioCentury | Oct 29, 2012
Financial News

ZS Pharma completes venture financing

...$46 million Investors: Alta Partners; Devon Park Bioventures; RiverVest Venture Partners; 3x5 Special Opportunity Partners; Salem Partners WIR...
BioCentury | Oct 24, 2012
Financial News

ZS Pharma raises $46M in C round

...investor Devon Park Bioventures joined new investors RiverVest Venture Partners; 3x5 Special Opportunity Partners; and Salem Partners...
BioCentury | Nov 29, 2006
Financial News

Quinnova raises $13.6 million

...led by Thomas, McNerney and H.I.G. Ventures. Omnivest (Bermuda) Ltd. also participated in the round. Salem Partners...
Items per page:
1 - 6 of 6
BioCentury | Jun 24, 2020
Finance

AsclepiX aims for basket of retinal indications with $35M series A

...November 2019 that it had raised $5 million via a convertible note from Barer, Rapha, Salem Partners...
BioCentury | Mar 10, 2014
Financial News

ZS Pharma completes venture financing

...Management; Adage Capital Management; Sofinnova Ventures; Alta Partners; Devon Park Bioventures; 3x5 Special Opportunity Partners; Salem Partners...
BioCentury | Mar 6, 2014
Financial News

ZS Pharma raised $55 million in D round

...also participated, along with existing investors Alta Partners; Devon Park Bioventures; 3x5 Special Opportunity Fund; Salem Partners...
BioCentury | Oct 29, 2012
Financial News

ZS Pharma completes venture financing

...$46 million Investors: Alta Partners; Devon Park Bioventures; RiverVest Venture Partners; 3x5 Special Opportunity Partners; Salem Partners WIR...
BioCentury | Oct 24, 2012
Financial News

ZS Pharma raises $46M in C round

...investor Devon Park Bioventures joined new investors RiverVest Venture Partners; 3x5 Special Opportunity Partners; and Salem Partners...
BioCentury | Nov 29, 2006
Financial News

Quinnova raises $13.6 million

...led by Thomas, McNerney and H.I.G. Ventures. Omnivest (Bermuda) Ltd. also participated in the round. Salem Partners...
Items per page:
1 - 6 of 6